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Summary
African trypanosomes infect a broad range of
mammals, but humans and some higher primates
are protected by serum trypanosome lytic factors
that contain apolipoprotein L1 (ApoL1). In the
human-infective subspecies of Trypanosoma
brucei, Trypanosoma brucei rhodesiense, a gene
product derived from the variant surface glyco-
protein gene family member, serum resistance-
associated protein (SRA protein), protects against
ApoL1-mediated lysis. Protection against trypano-
some lytic factor requires the direct interaction
between SRA protein and ApoL1 within the
endocytic apparatus of the trypanosome, but some
uncertainty remains as to the precise mechanism
and location of this interaction. In order to provide
more insight into the mechanism of SRA-mediated
resistance to trypanosome lytic factor, we
assessed the localization of SRA in T. b.
rhodesiense EATRO3 using a novel monoclonal
antibody raised against SRA together with a set of
well-characterized endosomal markers. By three-
dimensional deconvolved immunofluorescence
single-cell analysis, combined with double-
labelling immunoelectron microscopy, we found
that ≈ 50% of SRA protein localized to the lyso-
some, with the remaining population being dis-
tributed through the endocytic pathway, but
apparently absent from the flagellar pocket
membrane. These data suggest that the SRA/
trypanolytic factor interaction is intracellular, with
the concentration within the endosomes poten-
tially crucial for ensuring a high efficiency.
Introduction
Immune evasion for African trypanosomes has multiple
components. Antigenic variation is the primary mecha-
nism based on the monoallelic expression of the variant
surface glycoproteins (VSG; Cross, 1975). Additional
mechanisms assisting in defence against the host
immune system include rapid capping, endocytosis and
degradation of surface-bound immune complexes (Barry,
1979; Pal et al., 2003; Engstler et al., 2007). A third com-
ponent is responsible for resistance to innate immune
factors and dictates host range. In particular, this governs
the ability to infect humans and a number of higher
primates (Pays et al., 2014).
The immune effectors responsible for host restric-
tion are trypanolytic factor (TLF) 1 and 2, serum
macromolecular complexes which contain two primate-
specific proteins: haptoglobin-related protein (Hpr) and
apolipoprotein L1 (ApoL1). TLF1 enters the trypanosome
through binding of Hpr to the haptoglobin-haemoglobin
receptor (HpHbR) and clathrin-mediated endocytosis,
while ApoL1 causes trypanolysis via the transmembrane
flux of chloride and the osmotic swelling of the lysosome
(Vanhamme et al., 2003; Perez-Morga et al., 2005;
Thomson and Finkelstein, 2015). Trypanosomes that
infect humans have evolved mechanisms that negate
TLF-mediated killing. In the West Africa subspecies
Trypanosoma brucei gambiense, the resistance mecha-
nism appears to involve multiple factors, including
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alterations to TLF endocytosis by a polymorphism in the
HpHbR lowering the affinity for ligand (Vanhollebeke
et al., 2008; Higgins et al., 2013), expression of the
T. b. gambiense-specific glycoprotein TgsGP and reduc-
tion of sensitivity to ApoL1 through altered cysteine pro-
tease activity (Uzureau et al., 2013). In the East African
form, Trypanosoma brucei rhodesiense, a single serum
resistance-associated (SRA) gene is both necessary for
resistance to TLFs and sufficient to confer resistance on
otherwise sensitive Trypanosoma brucei brucei isolates
(De Greef and Hamers, 1994; Xong et al., 1998). The
mechanism of resistance is a stoichiometric binding of
SRA to ApoL1 that prevents ApoL1 trypanocidal action
(Pays et al., 2014).
To gain access to the lysosome via endocytosis, ApoL1
is trafficked through the endosomal system. Endocytosis
is exclusively clathrin-mediated in trypanosomes and
extremely rapid in the mammalian stages. Following the
initial endocytosis event at the flagellar pocket membrane,
cargo progresses through a series of endosomal
subcompartments that have been defined to some
degree, and which correspond broadly to early, middle
and late endosomes of mammalian cells plus recycling
sorting/endosomes; these are defined by the presence of
the small GTPases Rab 5, 21, 28 and 7 respectively for
the endocytic arm and Rab11 for the recycling pathways
(Manna et al., 2014).
Despite a considerable body of literature, it remains
unknown where the initial interaction between SRA and
ApoL1 occurs within the trypanosome endosomal system,
while descriptions of the localization of SRA within the cell
are not always consistent. Initial reports localized endog-
enous SRA to solely the lysosome by immunofluo-
rescence (IF), using p67 as the lysosomal marker
(Vanhamme et al., 2003). Subsequently, a wider distribu-
tion within the endosomal system, extending from the
flagellar pocket to the lysosome and including several
intermediate endosomes, was reported in a cell line
overexpressing a Ty epitope-tagged SRA transgene. In
this study, visualization of SRA in the lysosome required
the use of the lysosomal protease inhibitor FMK-024,
presumably to delay degradation of the SRA protein or Ty
epitope (Stephens and Hajduk, 2011). These conflicting
reports have significant impact in understanding the func-
tion of SRA and in particular, the likely site(s) of interac-
tion. Does SRA bind and inactivate TLF early in the
endocytic pathway or is the encounter later, at a point
close to the lysosome? These points are important as they
also influence the mechanism by which TLF is prevented
from accessing the lysosome; specifically, the intracellular
routes that are required to simply recycle TLF from early
endosomes are well established, but pathways to bring
material from late or terminal endosomes back to the
surface are poorly documented in trypanosomes. Here,
with high resolution three-dimensional deconvolved IF
(3D-IF), the subcellular localization of the SRA protein has
been investigated in cell lines over a range of expression
levels that spans the endogenous expression level in
T. b. rhodesiense and two T. b. brucei cell lines containing
SRA transgenes.
Results and discussion
Characterization of an SRA monoclonal antibody and
transgenic cell lines
The mature SRA polypeptide has ∼360 residues,
three potential N-linked glycosylation sites and a
glycosylphosphatidylinositol anchor at the C-terminus
(Vanhamme et al., 2003; Oli et al., 2006). SRA has struc-
tural similarity to VSG, and in particular the division into
a large N-terminal and smaller C-terminal domain. The
N-terminal domain, corresponding to residues 24 to 267,
has been modelled using a VSG template (Campillo and
Carrington, 2003). The region included in that model was
expressed as a recombinant protein in Escherichia coli
(Thomson et al., 2009) and used to generate monoclonal
antibodies in mice (Fig. 1A). A panel of hybridomas were
screened against recombinant SRA by ELISA (data not
shown) and positive clones were rescreened against
recombinant SRA by Western blot (WB) and finally,
whole cell lysates from T. b. rhodesiense and T. b. brucei
(Fig. 1B). Two monoclonal antibodies remained at this
point and the monoclonal anti-SRA (5D2) that gave
the strongest reactivity by WB was selected. MAb5D2
recognized a polypeptide of ∼50 kDa in lysates of
T. b. rhodesiense grown in the presence of human
serum, but did not recognize any antigens in lysates from
T. b. brucei or T. b. rhodesiense cultured for an extensive
period in the absence of human serum, a treatment fre-
quently resulting in silencing of the SRA gene (De Greef
and Hamers, 1994; Xong et al., 1998). MAb5D2 there-
fore represents a defined anti-SRA reagent with high
specificity.
As a member of the VSG family, SRA is predicted to
share similar structures with both VSGs and the trypano-
some transferrin receptor (De Greef and Hamers, 1994;
Carrington and Boothroyd, 1996). Evidence from in silico
modelling of the SRA protein suggests that there are two
disulphide bonds in the N-terminal domain of SRA. The
small C-terminal domain of SRA shares conserved
cysteine residues with the VSG C-terminal domains
(Campillo and Carrington, 2003), but, in SRA, there is an
additional cysteine present in the linker between the
N-terminal and C-terminal domain. Significantly, a minor-
ity of VSGs also possess a cysteine in an equivalent
position which forms an interchain disulphide bond in the
VSG dimer. To test if SRA is a disulphide-linked dimer,
J.-M. Bart et al.1524
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protein extracts of normal human serum (NHS)-resistant
T. b. rhodesiense (Tbr-R) were prepared in the absence
or presence of 100 mM of DTT. After WB analysis, DTT-
treated SRA protein migrated as the expected 50 kDa
single band, while two major species at ∼40 kDa and
∼70 kDa and a minor one at 130 kDa were detected for
the untreated extract (Fig. 1C). The most likely interpre-
tation is that the 40 kDa form is the SRA monomer with
disulphide bonds intact and the 70 kDa form is an SRA
dimer, suggesting that SRA is present as both disulphide-
bonded dimers and non-disulphide-bonded forms within
the cell. The higher molecular weight form may represent
an additional oligomeric state.
To create cell lines expressing different levels of SRA
protein, a transgene encoding the complete SRA open
reading frame, flanked by an actin 5’UTR and VSG
3’UTR, was introduced ∼400 bp downstream of the VSG
promoter in an expression site (Penate et al., 2009;
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Fig. 1. Characterization of an SRA monoclonal antibody and transgenic cell lines expressing SRA.
A. Schematic representation of the recombinant SRA protein used to generate the monoclonal antibody. GPI, glycosylphosphatidylinositol
anchor; HD, hinge domain; SP, signal peptide.
B. WB analysis with a mouse monoclonal antibody generated against SRA (mAb 5D2). Tubulin was used as loading control. Tbb,
Trypanosoma brucei brucei; Tbr-S, Trypanosoma brucei rhodesiense-human serum sensitive; Tbr-R, T. b. rhodesiense-human serum resistant.
C. WB analysis with anti-SRA of T. b. rhodesiense protein extracts in the presence or absence of 100 mM DTT.
D. Schematic representation of the plasmid used to ectopically express SRA in T. b. brucei.
E. WB analysis of T. b. brucei cell lines ectopically expressing SRA (LoSRA and HiSRA). BiP was used as loading control. Two exposure
times are shown (30 s as short exposure and 3 min as long exposure).
F. IF analysis of the endogenous SRA (green) expression pattern in T. b. rhodesiense. DNA is stained with DAPI. Scale bar: 5 μm.
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Fig. 1D). Cell lines containing the transgene were
screened by WB with the monoclonal anti-SRA and two
cell lines were selected for experiments, with one
expressing significantly less SRA (LoSRA) than
T. b. rhodesiense and one expressing more SRA (HiSRA;
Fig. 1E).
To confirm the correct folding of SRA and its ability to
confer resistance to NHS, both clones were grown in 5%
fresh and inactivated NHS, together with the T. b. brucei
S16 parental cell line. While S16 cells died within 24 h in
such conditions, the two transgenic SRA clones prolifer-
ated indistinguishably from T. b. rhodesiense (data not
shown) validating that the transgenic SRA was both
folding and being targeted correctly.
To localize SRA in T. b. rhodesiense cells, we carried
out 3D-IF microscopy on cells grown in the presence of
5% human serum. Statistical analysis of the SRA distri-
bution was performed using interphase cells (i.e. 1K1N)
and specifically excluding cells undergoing mitosis or
cytokinesis where SRA localization is significantly more
complex, most likely due to the replication and segrega-
tion of cellular organelles. Consistent with earlier studies,
SRA demonstrated significant distribution to regions of the
cell between the nucleus and kinetoplast, which is con-
sistent with a location throughout the endocytic pathway
(Fig. 1F). Significantly, we were unable to detect SRA at
the surface of the parasite or in a region close to the
kinetoplast, where the flagellar pocket resides, suggesting
that the majority of the SRA we were able to visualize
was present within internal cellular structures. For 70.5%
of the cells (n = 156), SRA concentrates in one or two
areas more proximal to the nucleus than kinetoplast
(see quantitation in Fig. 4B). Under our fixation and
permeabilization conditions [2% paraformaldehyde (PFA)
w/v and 1% NP40 v/v], SRA immunoreactivity was found
close to the flagellar pocket only in a very small proportion
of the cells (3.2%).
Endogenous SRA is partially associated with the
lysosome in T. b. rhodesiense
Because the subcellular localization of SRA has not been
definitively described in the literature (Vanhamme et al.,
2003; Stephens and Hajduk, 2011), we re-examined
SRA localization taking advantage of MAb5D2 and com-
bined this with high resolution 3D-deconvolution imaging
(Landeira et al., 2009) performed in T. b. rhodesiense. To
determine the proportion of colocalization between SRA
and the lysosome, two independent lysosomal markers
were used: p67 and TbCathepsin (TbCatL), a lysosomal
protease, also known as trypanopain (Caffrey et al.,
2001; Fig. 2A). Single-cell quantification was performed
from the 3D-deconvolved images using JACoP, a com-
ponent of ImageJ. Under permeabilizing conditions,
SRA partially localized with both lysosomal markers;
Pearson’s coefficients were statistically significant when
comparing SRA/TbCAtL (rp = 0.69 ± 0.07) and SRA/p67
(rp = 0.50 ± 0.11) with the Pearson’s coefficient calcu-
lated to examine the colocalization between SRA
and BiP and endoplasmic reticulum (ER) marker
(rp = 0.33 ± 0.08; Fig. 2B). As a marker of recycling
endosomes we used an antibody to TbRab11 and double
IF was carried out with anti-SRA MAb5D2 (Fig. 2A, lower
panel). No colocalization was found between both pro-
teins (rp = 0.19 ± 0.13), discarding the possibility of a sig-
nificant presence for SRA in the exocytic or recycling
pathways. Finally, to assess a possible location of SRA in
the flagellar pocket area as previously suggested
(Stephens and Hajduk, 2011), we combined anti-SRA
with a rabbit polyclonal anti-FTZC antibody that was
described as a component of the flagellum transition
zone, located at the base of the flagellum (Bringaud
et al., 2000). Double IF followed by single-cell analysis
failed to detect any significant colocalization between
SRA and FTZC (rp = 0.08 ± 0.04; Fig. 2A and B), sug-
gesting that in endogenous conditions, SRA does not
traffic through flagellar pocket area.
For both lysosomal markers that showed significant
colocalization, we decided to apply Mander’s M1 and M2
coefficients that quantitate the portion of the intensity in
each channel that coincides with some intensity in the
other channel. These data represent the ratio of inter-
secting volumes, but considering each channel sepa-
rately. For cells stained with TbCatL and SRA, 49.5%
(±16.1%) of the signal detected for TbCatL (M1) coin-
cided with SRA signal, while 67.6% (±16.3%) of SRA
(M2) coincided with TbCatL (Fig. 2C). Congruently with
the Pearson’s coefficient data calculated for p67 and
SRA, Mander’s coefficients decreased in comparison
with the TbCatL/SRA relation with 39.9% (±15.2%) of
p67 signal (M1) that coincided with SRA and 36.8%
(±18.1%) of SRA signal (M2) coinciding with p67. These
results strongly support that SRA traffics to the lyso-
some, as approximately half of the SRA is detected in
this compartment.
To confirm the SRA subcellular distribution analysed
by 3D-IF, we decided to conduct immunoelectron
microscopy (IEM) combining anti-p67 (lysosome) and
anti-FTZC with the monoclonal anti-SRA antibody. To
guarantee relevant IEM labelling conditions, antibodies
were first studied separately. As expected, both rabbit
polyclonal antibodies gave a characteristic pattern
shown in Fig. 3A for anti-p67 and in Fig. 3B and C for
anti-FTZC. Despite the low sensitivity of the antibody, a
specific anti-SRA MAb5D2 signal was observed; 15 nm
gold particles were associated with vesicles as revealed
in Fig. 3D. We thus decided to perform double IEM,
combining anti-SRA either with anti-p67 or anti-FTZC.
J.-M. Bart et al.1526
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We first ensured the lack of cross-reaction between the
first and the second antibodies (data not shown) and
then performed double IEM. Congruently with the 3D-IF
observations, SRA was never found associated with
FTZC or the flagellar pocket area (Fig. 3E) while partial
colocalization of SRA/p67 was confirmed (Fig. 3F). From
all these data, we can also hypothesize that the remain-
ing SRA signal that does not associate with the lyso-
some vesicles could be connected with the endosomal
structures.
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Fig. 2. SRA partially associates with lysosome.
A. Representative pictures of double 3D-IF combining rabbit polyclonal anti-cathepsin, anti-p67, anti-Rab11 or anti-FTZC antibodies (red) with
the mouse monoclonal anti-SRA (5D2) antibody (green). The colocalization colour map (inset) shows the intensity of colocalization between
SRA and the red-labelled endocytic markers as indicated by the colour bar. In these colour maps, the −1 to +1 heat map depicts the
measured icorr values. Negatively correlated relationships (icorr values between −1 and 0) are shown in blue-green colours, whereas positive
correlations (icorr values between 0 and 1) are represented by warmer yellow-red colours. Scale bar: 1 μm.
B and C. Colocalization analysis. Pearson’s coefficient was calculated for each individual 3D-deconvolved image (n = 70). *P-value < 0.05.
Mander’s coefficients were calculated (when Pearson’s coefficient ≥ 0.5) to define the M1 and M2 as the percentages of pixels in one channel
(M1 = red) that intersect with some signal in other channel (M2 = green). Both coefficients were assessed using ‘JACoP’, a colocalization
plug-in available in Image J.
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Overexpression of SRA affects subcellular localization
To determine if the location of SRA is influenced by copy
number, we conducted SRA IF on our transgenic
T. b. brucei cells that are under- or overexpressing
SRA (Fig. 4). As for endogenous expression in
T. b. rhodesiense, statistical analysis was performed of
the SRA distribution in 1K1N cells (Fig. 4A for IF and
Fig. 4B for statistical data). For the LoSRA line, the locali-
zation of SRA was comparable with that obtained from
T. b. rhodesiense, with ∼70% to 80% of the cells exhibiting
SRA as one or two punctae suggesting restriction to the
lysosome and endosomes. No association was observed
with the ER, as revealed by a rabbit polyclonal anti-BiP
antibody (Fig. 4A). For the HiSRA cell line, we found that
SRA localization was significantly more extensive, with
36.9% (±3.8%) of the cells displaying a localization that
was distinct to T. b. rhodesiense, while 32.6% (±2.4%) of
cells exhibited SRA in the flagellar pocket area. Addition-
ally, for these cells, colocalization with BiP was observed,
suggesting that when overexpressed SRA is not efficiently
folded or exported and remains within the ER and possi-
bly Golgi apparatus (Fig. 4A).
Inhibition of endocytosis does not affect the
endogenous SRA location in T. b. rhodesiense
In order to better assess the possibility that SRA traffics
into the flagellar pocket, despite having an undetectable
presence at steady state, we used two approaches to
disrupt endocytosis. We reasoned that if even small levels
of SRA were present within the flagellar pocket, the block-
ade to endocytic trafficking would result in accumulation
of SRA at that site and facilitate the detection of SRA that
was essentially en route via the surface.
Firstly, we monitored the location of fluorescein
isothiocyanate (FITC)-labelled lectin Concanavalin A (Con
A) and 488-labelled human transferrin (HT-488) in mid-log
phase bloodstream form (BSF) T. b. rhodesiense at 4, 14
and 37 C. Both reagents report on endocytosis of surface
protein; Con A by binding oligomannose N-glycans
Fig. 3. Colocalization of SRA to the vicinity of lysosomes in Trypanosoma brucei rhodesiense NHS-resistant cell line by double-labelling IEM.
Cells were first labelled either with rabbit anti-p67 (A) or rabbit anti-FTZC (B and C) or mouse anti-SRA (D) antibodies. Double-labelling was
then performed with anti-SRA/anti-FTZC (E) and anti-SRA/anti-p67 (F). Arrowheads indicate SRA labelling (15 nm gold particles conjugated)
and arrows indicate p67 or FTZC labelling (5 nm gold particles conjugated). fp, flagellar pocket; ly, lysosome; tz, transition zone. Scale bar:
1 μm.
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(essentially VSG) and transferrin by binding the ESAG6/7
transferrin receptor. Con A and HT-488 labelling was fol-
lowed by immunostaining with anti-FTZC (Bringaud et al.,
2000) after fixation and permeabilization (Fig. 5A). For
both reagents, low temperature clearly led to a decrease
in endocytosis as expected. At 4°C, Con A and HT-488
were retained at the flagellar pocket, as colocalization
with FTZC proved. This association was progressively lost
when temperature increased. At 14°C, Con A and HT-488
are internalized to the endocytic system and at 37°C, both
compounds reached the lysosome (Fig. 5A). We thus
decided to use such conditions to assess the subcellular
location of SRA upon endocytic perturbation (Fig. 5C and
D). Significantly, the localization of SRA was unaltered by
these low temperature treatments, retaining indistinguish-
able distributions to our previous physiological conditions.
While no evidence of SRA enrichment in the flagellar
pocket area was detected, colocalization of SRA with Con
A and HT was significant when these fluorophores were
endocytosed and trafficked through endosomes to the
lysosome (see statistics in Fig. 5B).
Low temperature is not only a specific endocytic
pathway inhibition, but also perturbs exocytosis and
many other cellular processes (Yeaman et al., 2001).
Exocytosis to the cell surface is via the flagellar pocket
(Grunfelder et al., 2003; Sutterwala et al., 2007) and
alterations to exocytosis could modulate the inhibition of
endocytosis and mask a putative enrichment of SRA in
the flagellar pocket. Therefore, to inhibit endocytosis in a
very distinct manner, we suppressed expression of
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the clathrin heavy chain (TbCLH) by RNA interference
(RNAi). Knockdown (KD) of clathrin results in an enlarge-
ment of the flagellar pocket, suggesting that membrane
delivery is unaffected but removal is blocked (Allen et al.,
2003). As T. b. rhodesiense EATRO3 does not contain
the relevant transgenic elements for RNAi, we decided to
take advantage of the T. b. brucei cell line expressing
SRA (LoSRA).
We first monitored TbCLH depletion by measuring the
uptake of Alexa-488 (HT-488) HT by flow cytometry. After
only 8 h of RNAi induction, HT-488 uptake was reduced
by 58.2% (±5.1%; Fig. 6A). To confirm this, fluorescence
microscopy was also used. Statistical analysis performed
on a total of 372 cells, analysed in two independent
experiments, showed that under normal conditions, for
90.1% (±1.8%) of the cells, HT was localized in the
endosomes/lysosome area after 10 min of uptake
(Fig. 6B). Consistent with the flow cytometry, under
TbCLH-KD, 75.4% (±2.7%) of the cells retain HT in the
flagellar pocket area, while the remaining cells did not
show any labelling (Fig. 6B).
Single-cell analysis (n = 88) of 3D-deconvolved pictures
was performed using a colocalization colour map to
ascertain the impact on SRA. Rapid transferrin uptake in
the parental cell line leads to partial colocalization
between the HT-488 and SRA in the endosomes/
lysosome area (98% of the cells, Fig. 6C). For the TbCLH-
induced RNAi line (LoSRA-TbCLH-KD), SRA was not
significantly associated with HT. A colocalization mask
indicated 11.5% of the cells with overlapping between
HT-488 and SRA (with a non-significant P-value = 0.111
with Fisher’s exact test), suggesting than upon such con-
dition of strong endocytic inhibition, SRA did not signifi-
cantly enrich in the flagellar pocket area (Fig. 6C and D),
suggesting that SRA does not commonly traffic there.
SRA represents a key protein that confers full human
serum resistance when expressed in Trypanosoma
brucei and its intracellular itinerary is crucial to under-
standing the function, as the location of SRA determines
where it interacts with TLF. Previous work on SRA
subcellular localization lead to contradictory data
(Vanhamme et al., 2003; Stephens and Hajduk, 2011).
Here, we attempt, using a new reagent combined with
modulation of expression and trafficking, to determine
specifically if SRA is either at the surface, in the flagellar
pocket area or in the endocytic pathway. In summary, our
data suggest that SRA is present at the internal mem-
branes, but that even with an endocytosis block, its
detection at the cell surface is not significant, suggesting
that the flagellar pocket does not represent a major site
for interaction between SRA and TLF (Fig. 7). The con-
centration of SRA within endosomes may act as a
mechanism to increase the local concentration and
therefore ensure efficient sequestration of TLF.
Experimental procedures
Ethics statement
Human blood samples were taken from healthy donors, who
provided written informed consent for the collection of samples.
These samples were specifically obtained for this study. The
procedure was approved by the ethical committee of the Institute
of Parasitology and Biomedicine Lopez-Neyra (Spanish National
Research Council).
Trypanosomes
Trypanosoma brucei rhodesiense East African Trypanosomiasis
Research Organization (EATRO3 ETat1.2 TREU164; Turner
et al., 2004) and T. b. brucei single marker [derived from T. brucei
bloodstream, Molteno Institute Trypanozoon antigenic type
(MITat) 1.2; clone 221a] cell lines (Wirtz et al., 1999), grown in
Hirumi’s Modified Iscove (HMI)-9 medium supplemented with
10% inactivated fetal calf serum (Hirumi and Hirumi, 1989) or 5%
inactivated NHS, were used for all the experimental procedures.
Production of the monoclonal antibody raised
against SRA
His-tagged recombinant SRA (residues 24 to 267) was
expressed in E. coli from plasmid p3303, a pET15b derivative
(Thomson et al., 2009). The polypeptide was purified using nickel
ion affinity chromatography under standard conditions. A BALB/c
mouse was immunized by three intraperitoneal injections of
50 μg of purified recombinant SRA. Three days before fusion,
40 μg of the protein was injected intravenously. Normal antibody-
producing spleen cells were fused with immortal myeloma cells.
The hybridoma that produced the desired antibody was selected
by ELISA and subcloned to obtain a single epitope antibody,
which was named 5D2. This monoclonal antibody was tested by
WB and IF against Tbr-R, NHS-sensitive T. b. rhodesiense
(Tbr-S) and T. b. brucei cell lines.
SRA expressing trypanosome
The SRA open reading frame was cloned by PCR using
oligonucleotides 5′GGATCCATGCCCCGAAATTCGGGCCG-3′
and 5′-GGATCCTTAAAACAGAAAGGCCACAA-3′, digested with
BamHI (underlined nucleotides) and cloned into an expression
vector (pMig104) designed to integrate 405 bp downstream of
the active Expression Site (ES) promoter (Penate et al., 2009).
Correct orientation was confirmed by sequencing. The 221-VSG
3′UTR was cloned by PCR using oligonucleotides 5′-ATGGATC
CACCCCTCTTTGGCTTGCAGTT-3′ and 5′-CTCGGGCCCG
TCCAGGATAGAGGTGTGAGTTAAA-3′, digested with BamHI
and SmaI, respectively, and inserted downstream of the SRA
Open Reading Frame (ORF) stop codon. T. b. brucei
bloodstream-formed single marker trypanosomes were
transfected and selected with 5 μg ml−1 bleomycin using proce-
dures previously described (Wirtz et al., 1999). Transformants
were called LoSRA and HiSRA.
RNAi procedure
To generate clathrin-depleted cell lines, the plasmid p2T7TiCLH
was transfected into the LoSRA (Allen et al., 2003).
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Transformants were selected with 2.5 μg ml−1 of G418, 5 μg ml−1
of hygromycin and 5 μg ml−1 of bleomycin. Clones were induced
with tetracycline and selected for growth defect and transferrin
uptake decrease (see Uptake assays).
Protein electrophoresis and WB
For protein extraction, mid-log phase cells were harvested,
washed in TDB-glucose and resuspended in SDS-
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polyacrylamide sample buffer at a concentration of 1 × 106 cell
equivalents per microlitre. Samples were electrophoresed on
10% SDS-PAGE gels at 5 × 106 cell equivalents per lane and
then transferred to Hybond-ECL nitrocellulose membrane
(Amersham Pharmacia Biotech). Transfer and equivalence of
loading were checked by staining the membrane with Ponceau S
solution (Sigma) prior to blocking for 20 min at room temperature
in blocking solution (PBS supplemented by 5% dried milk). Mem-
branes were incubated for 1 h at room temperature with primary
antibody at the appropriate dilution in 0.5% blocking solution
(mouse monoclonal anti-TbSRA antibody was diluted 1:10, the
mouse monoclonal anti-tubulin 1:5000 and the rabbit anti-Bip
1:20 000), washed 3 × 10 min in PBS/0.05% Tween-20, then
incubated for 1 h with horseradish peroxidase goat anti-mouse
conjugate (GE Healthcare). After washing, bound antibodies
were detected by reaction with luminol and visualized by expo-
sure to X-ray film.
Uptake assays
For colocalization studies of SRA with FITC-labelled Con A
(Vector Laboratories) and human holo-Tf Alexa Fluor 488-
conjugated (HT-488) (Invitrogen), uptake assays were performed
as followed. A total of 2 × 106 parasites, previously washed with
TDB-glucose plus 1% BSA and cooled down for 10 min at 4°C,
were incubated with 10 μg FITC-Con A or 5 μg HT-488 at the
appropriate temperatures (4, 14 and 37°C) for 30 min in a volume
of 250 μl. After incubation, cells were fixed for 1 h at 4°C in 1%
PFA diluted in cold TDB. Cells were finally washed twice with
TDB to remove unlabelled Con A or HT-488 and PFA and were
kept at 4°C before IF.
For analysis of HT uptake by flow cytometry, 2 × 106
trypanosomes were harvested and washed with TDB-glucose
plus 1% BSA, resuspended in 250 μl in the same buffer and
incubated for 10 min at 37°C. Then, 5 μg of HT-488 were added.
Incubations were carried out for 0 (no Tf), 1, 2.5, 5 and 10 min at
37°C. Cells were then fixed at least for 1 h at 4°C in 1% PFA
diluted in cold PBS. Parasites were finally washed twice with
PBS and labelled cells were analysed with a Becton Dickinson
FACSCaliburTM flow cytometer (BD Biosciences) using BD
CellQuest™ Pro version 4.0.2 software (Cordon-Obras et al.,
2013).
3D-IF
Cellular localization analysis was performed by 3D-IF as
described previously (Landeira et al., 2009). Images displayed in
the figures are maximum intensity projections from digitally
deconvolved multichannel 3D image datasets using Huygens
Essential software v. 2.9 (Scientific Volume Imaging). Cells were
fixed with 2% PFA for 1 h and permeabilized with 1% NP40 for
30 min. IF analysis was carried out in 0.5% blocking reagent
(Roche) in PBS (Sigma) using the mouse monoclonal anti-
TbSRA antibody (5D2) (1:50), the rabbit polyclonal anti-BiP
(1:20000), anti-p67 (1:4000), anti-TbCat (1:4000), anti-Rab11
(1:250) and anti-FTZC (1:2000) antibodies. Pseudocolouring and
maximum intensity projections were performed using ImageJ
software v. 1.43 (National Institutes of Health). Deconvolution of
3D images was performed using Huygens Essential software
(version 2.9; Scientific Volume Imaging) using an experimentally
calculated point-spread function with 0.2-μm TetraSpeck
microspheres (Invitrogen). For the colocalization analysis,
JACoP and Colocalization Colormap, available under Image J,
were used. Live-cell imaging was performed at 37°C and cells
were visualized under differential interference contrast optics.
IEM
Parasites were washed in TDB-glucose and fixed in 4% PFA and
0.25% glutaraldehyde in PBS, pH 7.4, 1 h at 4°C. The cell pellet
was embedded in LRWhite resin (Electron Microscopy Science)
and polymerized at −20°C with ultraviolet light. Thin sections
(50–70 nm) were cut and probed with anti-SRA (1:2), anti-p67
(1:4000) and/or anti-FTZC (1:2000) antibodies diluted PBS with
1% BSA, 0.5% Tween 20 (Sigma), 2 h at room temperature.
Primary antibody incubation was followed by 1:30 dilution goat
anti-mouse (15 nm) and/or anti-rabbit (5 nm) gold conjugated
antibodies (British Biocell International) incubation for 1 h.
Control preparations processed without primary antibody and
irrelevant primary antibodies were all negative.
Statistical analysis
We used one-way analysis of variance to compare the Pearson’s
coefficient value generated by the JACoP analysis. Confidence
intervals were set at 95%. IBM SPSS Statistics software (version
20) was used to perform the statistical analysis.
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Fig. 7. Schematic model of SRA subcellular localization in
Trypanosoma brucei rhodesiense, inferred from the data obtained
with the mouse monoclonal anti-SRA antibody. Double IFs and
IEMs, combining anti-SRA with various endocytic pathway markers,
through endogenous conditions and/or compromising physically or
molecularly the endocytosis, indicate that SRA traffics from
lysosomes to endosomes, avoiding the flagellar pocket area. Our
data suggest that the SRA interacts with the trypanolytic factor in
an intracellular manner, with the concentration within the
endosomes potentially crucial for increasing efficiency.
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